NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Generational wealth is coming faster than the longs can dream about. This will always be my first line on my post which is allowed only one for each day.

Did you see LP mentioned about the collaboration trial with Penn about DCVax-L? Have you read the published results? Did you notice what those researchers had been doing over the past many years?

$NWBO also had a collaboration trial on the Direct with Mayo Clinic. There are a bunch of DC vaccine trials conducted by Mayo that produced truly amazing results. Can you go through some of my posts on X and let me know how you feel?

No one can ruin my investment!!!

And just one last thing to remind you on that: Northwest already has a history itself in ovarian cancer. You may remember that we did a small pilot trial with DCVax-L in ovarian cancer, and it was quite strikingly encouraging at the time. We could only do the small pilot, but the academic collaborators we did that trial with many years ago, who were at Penn, and Penn has a center of excellence in ovarian cancer, they did go onwards and treat some more patients beyond what we could do, and they continued to get good results, and those results have been published.

$NWBO

LP mentioned about the collaboration trial on DCVax-L with Penn. What about the Direct trial with Mayo Clinic?
There are a bunch of DC vaccine trials from Mayo Clinic that delivered truly amazing results.

Dendritic Cell Therapy for Brain Metastases From Breast- or Lung… pic.twitter.com/yi44XeAaPi

— d_stock (@d_stock07734) December 30, 2025

$NWBO

And just one last thing to remind you on that: Northwest already has a history itself in ovarian cancer. You may remember that we did a small pilot trial with DCVax-L in ovarian cancer, and it was quite strikingly encouraging at the time. We could only do the small… https://t.co/dpymFtyVPT pic.twitter.com/A4vvS0qcXM

— d_stock (@d_stock07734) December 30, 2025

$NWBO

We’ve selected that indication. It is a non-brain cancer. It is below the neck.

LP mentioned that the single target for the phase 2 Direct trial has been selected. The following are the trials that were conducted by Mayo Clinic possibly onwards after the collaboration… https://t.co/ZWJzXwgK4G pic.twitter.com/gBR6GV57kJ

— d_stock (@d_stock07734) December 30, 2025

$NWBO

The following two ovarian cancer trials conducted by UPenn could be the ones implied by LP today. They were posted before. I doubt the longs read them. In case someone still has interest.

By now, should the longs know why BPs cannot acquire any DC vaccine technologies… https://t.co/ZWJzXwgK4G pic.twitter.com/S2Uo4DsAq3

— d_stock (@d_stock07734) December 30, 2025

$NWBO

The results of the ovarian trial were never published. But according to what LP said today at ASM, the results were quite strikingly encouraging. Pfizer's pneumococcal conjugate vaccine, Prevnar (PCV7) and Roche's VEGF inhibitor were included in the trial. Now Pfizer has… https://t.co/ZWJzXwgK4G pic.twitter.com/oJeyqxAEky

— d_stock (@d_stock07734) December 30, 2025

$NWBO

This trial on using the combination of DCVax-L with TLR agonists to treat brain tumor was licensed DC vaccine technology from $NWBO. The trial was finished enrollment the end of 2015. Would Merck or Eikon have struck those cheap deals with Immune design or 7&8 biopharma if…

— d_stock (@d_stock07734) December 29, 2025

$NWBO

See how Pandion got the deal done?

If LP cannot get what she wants, 900m shares can support $NWBO until 2028 when Merck hits the patent cliff.https://t.co/DeFTHSs8Qh https://t.co/ZcLcTfieRv pic.twitter.com/ALX5fufvPH

— d_stock (@d_stock07734) December 29, 2025